Skip to content
Companies

Cancer IQ

Hereditary cancer risk screening software for clinics

Raised to date

$4.3M

of $6M offered across 1 Form D filing

Still open
$1.7M
Investors
9
Last filed
May 26, 2026

About

CancerIQ is a Chicago-based precision health software company founded in 2013 out of the University of Chicago. Its cloud platform helps hospitals and clinics identify patients at elevated cancer risk, stratify them using evidence-based guidelines such as NCCN and Tyrer-Cuzick, and move them through genetic counseling, testing, and follow-up screening. The software integrates with existing EHR systems and automates pedigree generation, care-plan creation, insurance pre-authorization documentation, and adherence tracking. The company reports deployment across 275+ clinic locations nationwide.

Turns hereditary cancer risk assessment into an automated, EHR-integrated workflow rather than a manual genetic-counselor task, and reports measurable outcomes for health systems: 2.2x more completed genetic tests, 4.2x more supplemental screening, and an 8.9x average ROI.

Funding

  • Security to be acquiredFiled May 26, 2026Form D/A
    $4.3M/ $6M

Product

CancerIQ Platform

Clinical software platform

A precision health platform that lets providers identify, evaluate, and manage whole patient populations by individual genetic risk, then connect each patient to the right cancer prevention, screening, and diagnostic pathway.

  • Automated cancer risk assessment and patient stratification using NCCN and Tyrer-Cuzick guidelines
  • Automated family history pedigree generation
  • Genetic testing marketplace integration and insurance pre-authorization documentation

Built for

Health systems and hospitals running cancer prevention, breast center, oncology, and genetics programs, plus diagnostic companies and population health programs

People on file